These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Imaging of the myocardium using (18)F-FDG-PET/MRI. Ferda J; Hromádka M; Baxa J Eur J Radiol; 2016 Oct; 85(10):1900-1908. PubMed ID: 27470994 [TBL] [Abstract][Full Text] [Related]
27. Clinical Utility of Combined FDG-PET/MR to Assess Myocardial Disease. Abgral R; Dweck MR; Trivieri MG; Robson PM; Karakatsanis N; Mani V; Padilla M; Miller M; Lala A; Sanz J; Narula J; Fuster V; Contreras J; Kovacic JC; Fayad ZA JACC Cardiovasc Imaging; 2017 May; 10(5):594-597. PubMed ID: 27372018 [No Abstract] [Full Text] [Related]
28. Magnetic resonance imaging (MRI) for the assessment of myocardial viability: an evidence-based analysis. Medical Advisory Secretariat Ont Health Technol Assess Ser; 2010; 10(15):1-45. PubMed ID: 23074392 [TBL] [Abstract][Full Text] [Related]
29. (18)F-Fluorodeoxyglucose PET/MR Imaging in Head and Neck Cancer. Platzek I PET Clin; 2016 Oct; 11(4):375-86. PubMed ID: 27593244 [TBL] [Abstract][Full Text] [Related]
30. Optimization of the reference region method for dual pharmacokinetic modeling using Gd-DTPA/MRI and (18) F-FDG/PET. Poulin É; Lebel R; Croteau É; Blanchette M; Tremblay L; Lecomte R; Bentourkia M; Lepage M Magn Reson Med; 2015 Feb; 73(2):740-8. PubMed ID: 24604379 [TBL] [Abstract][Full Text] [Related]
31. Potential influence of Gadolinium contrast on image segmentation in MR-based attenuation correction with Dixon sequences in whole-body 18F-FDG PET/MR. Ruhlmann V; Heusch P; Kühl H; Beiderwellen K; Antoch G; Forsting M; Bockisch A; Buchbender C; Quick HH MAGMA; 2016 Apr; 29(2):301-8. PubMed ID: 26667965 [TBL] [Abstract][Full Text] [Related]
32. Comparison of cardiac magnetic resonance imaging and fluorodeoxyglucose positron emission tomography in the assessment of myocardial viability: meta-analysis and systematic review. Adhaduk M; Paudel B; Liu K; Ashwath M; Gebska MA; Delcour K; Samuelson RJ; Giudici M J Nucl Cardiol; 2023 Dec; 30(6):2514-2524. PubMed ID: 37758962 [TBL] [Abstract][Full Text] [Related]
33. 18F-FDG-PET/CT better localizes active spinal infection than MRI for successful minimally invasive surgery. Nakahara M; Ito M; Hattori N; Magota K; Takahata M; Nagahama K; Sudo H; Kamishima T; Tamaki N; Iwasaki N Acta Radiol; 2015 Jul; 56(7):829-36. PubMed ID: 25080515 [TBL] [Abstract][Full Text] [Related]
34. Combined Cardiac Fluorodeoxyglucose-Positron Emission Tomography/Magnetic Resonance Imaging Assessment of Myocardial Injury in Patients Who Recently Recovered From COVID-19. Hanneman K; Houbois C; Schoffel A; Gustafson D; Iwanochko RM; Wintersperger BJ; Chan R; Fish JE; Howe KL; Thavendiranathan P JAMA Cardiol; 2022 Mar; 7(3):298-308. PubMed ID: 35019953 [TBL] [Abstract][Full Text] [Related]
35. Vasudevan P; Gäbel R; Stenzel J; Förster J; Kurth J; Vollmar B; Krause BJ; Ince H; David R; Lang CI Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32397287 [TBL] [Abstract][Full Text] [Related]
37. Expanding the versatility of cardiac PET/CT: feasibility of delayed contrast enhancement CT for infarct detection in a porcine model. Holz A; Lautamäki R; Sasano T; Merrill J; Nekolla SG; Lardo AC; Bengel FM J Nucl Med; 2009 Feb; 50(2):259-65. PubMed ID: 19164240 [TBL] [Abstract][Full Text] [Related]
38. FDG PET/CT: normal variations and benign findings--translation to PET/MRI. Beheshti M; Kim CK PET Clin; 2014 Apr; 9(2):xiii-xiv. PubMed ID: 25030290 [No Abstract] [Full Text] [Related]